The perplexing problem of persistently PCR-positive personnel
[...]of using the test-based strategy, many institutions now have significant numbers of staff whose nasopharyngeal swabs remain RT-PCR positive for COVID-19, despite the fact that they have recovered from their episodes of illnesses and have been asymptomatic for weeks or, in some instances, months...
Gespeichert in:
Veröffentlicht in: | Infection control and hospital epidemiology 2021-02, Vol.42 (2), p.203-204 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 204 |
---|---|
container_issue | 2 |
container_start_page | 203 |
container_title | Infection control and hospital epidemiology |
container_volume | 42 |
creator | Henderson, David K Weber, David J Babcock, Hilary Hayden, Mary K Malani, Anurag Wright, Sharon B Murthy, A Rekha Guzman-Cottrill, Judith Haessler, Sarah Rock, Clare Van Schooneveld, Trevor Logan, Latania Forde, Corey |
description | [...]of using the test-based strategy, many institutions now have significant numbers of staff whose nasopharyngeal swabs remain RT-PCR positive for COVID-19, despite the fact that they have recovered from their episodes of illnesses and have been asymptomatic for weeks or, in some instances, months. [...]regarding the standardization of testing, if the clinical laboratory community developed universal standards for SARS-CoV-2 similar to the World Health Organization’s standards for hepatitis B and C, a multicenter study of all currently manufactured SARS-CoV-2 nucleic acid amplification tests could be designed to correlate the cycle threshold values on each platform for patients who have positive and negative viral cultures. Fewer data are available on viral viability duration in this latter population, and the need for further research on this topic is urgent. [...]based on these data, one approach to managing recovered HCP who work primarily with patient populations at high risk of complications would be to use the “time from symptom development” strategy plus “sustained improvement in respiratory symptoms” and add a safety factor (eg, adding an additional week or 2) to the time from symptom onset, or perhaps adding 2 weeks from test positivity for asymptomatic staff detected as positive. Conflicts of interest All authors report no conflicts of interest relevant to this article. *After this manuscript was submitted and accepted, the Centers for Disease Control and Prevention modified their recommended “return to work” criteria to state that a test-based strategy is no longer recommended and to advocate strategies basically consistent with the suggestions outlined in this paper (See https://www.cdc.gov/coronavirus/2019-ncov/hcp/return-to-work.html).References 1. |
doi_str_mv | 10.1017/ice.2020.343 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7417974</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2730823697</sourcerecordid><originalsourceid>FETCH-LOGICAL-c493t-3405f25de30e9badda7903070e2e924ec984af01b51522902d2d51e679eaad013</originalsourceid><addsrcrecordid>eNpdkc1L9DAQh4Mouq7ePMuCFw92nUzSTXPwhZfFLxAUUfAWsu1UI92mJl3R_96sX6ingczDj9_kYWyHw5gDV4eupDECwlhIscIGPM91NimEXGUDKLTOChR3G2wzxkcAUFrzdbYhUCnUEgfs6OaBRh2FrqEX196PuuBnDc1Hvl6-Rhd7avvmdXQ1vc46H13vnt_56NuWmi22Vtsm0vbnHLLbk-Ob6Vl2cXl6Pv1_kZVSiz4TEvIa84oEkJ7ZqrJKgwAFhKRRUqkLaWvgs5zniBqwwirnNFGarK2AiyH795HbLWZzqsrUKdjGdMHNbXg13jrze9O6B3Pvn42SXGklU8D-Z0DwTwuKvZm7WFLT2Jb8IhqUAosJ8lR3yPb-oI9-Edp0nkElIH3nRKtEHXxQZfAxBqq_y3AwSy8meTFLLyZ5SfjuzwO-4S8R4g2T0okV</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2730823697</pqid></control><display><type>article</type><title>The perplexing problem of persistently PCR-positive personnel</title><source>MEDLINE</source><source>ProQuest Central</source><source>Cambridge University Press Journals Complete</source><creator>Henderson, David K ; Weber, David J ; Babcock, Hilary ; Hayden, Mary K ; Malani, Anurag ; Wright, Sharon B ; Murthy, A Rekha ; Guzman-Cottrill, Judith ; Haessler, Sarah ; Rock, Clare ; Van Schooneveld, Trevor ; Logan, Latania ; Forde, Corey</creator><creatorcontrib>Henderson, David K ; Weber, David J ; Babcock, Hilary ; Hayden, Mary K ; Malani, Anurag ; Wright, Sharon B ; Murthy, A Rekha ; Guzman-Cottrill, Judith ; Haessler, Sarah ; Rock, Clare ; Van Schooneveld, Trevor ; Logan, Latania ; Forde, Corey ; SHEA Board of Trustees ; for the SHEA Board of Trustees</creatorcontrib><description>[...]of using the test-based strategy, many institutions now have significant numbers of staff whose nasopharyngeal swabs remain RT-PCR positive for COVID-19, despite the fact that they have recovered from their episodes of illnesses and have been asymptomatic for weeks or, in some instances, months. [...]regarding the standardization of testing, if the clinical laboratory community developed universal standards for SARS-CoV-2 similar to the World Health Organization’s standards for hepatitis B and C, a multicenter study of all currently manufactured SARS-CoV-2 nucleic acid amplification tests could be designed to correlate the cycle threshold values on each platform for patients who have positive and negative viral cultures. Fewer data are available on viral viability duration in this latter population, and the need for further research on this topic is urgent. [...]based on these data, one approach to managing recovered HCP who work primarily with patient populations at high risk of complications would be to use the “time from symptom development” strategy plus “sustained improvement in respiratory symptoms” and add a safety factor (eg, adding an additional week or 2) to the time from symptom onset, or perhaps adding 2 weeks from test positivity for asymptomatic staff detected as positive. Conflicts of interest All authors report no conflicts of interest relevant to this article. *After this manuscript was submitted and accepted, the Centers for Disease Control and Prevention modified their recommended “return to work” criteria to state that a test-based strategy is no longer recommended and to advocate strategies basically consistent with the suggestions outlined in this paper (See https://www.cdc.gov/coronavirus/2019-ncov/hcp/return-to-work.html).References 1.</description><identifier>ISSN: 0899-823X</identifier><identifier>EISSN: 1559-6834</identifier><identifier>DOI: 10.1017/ice.2020.343</identifier><identifier>PMID: 32772942</identifier><language>eng</language><publisher>United States: Cambridge University Press</publisher><subject>Asymptomatic ; Communicable Diseases ; Conflicts of interest ; Coronaviruses ; COVID-19 ; Disease control ; Disease prevention ; Disease transmission ; Hospitalization ; Humans ; Illnesses ; Infections ; Medical laboratories ; Nucleic acids ; Pandemics ; Patient safety ; Polymerase Chain Reaction ; SARS-CoV-2 ; Severe acute respiratory syndrome coronavirus 2 ; State of the Pandemic</subject><ispartof>Infection control and hospital epidemiology, 2021-02, Vol.42 (2), p.203-204</ispartof><rights>2020 by The Society for Healthcare Epidemiology of America. All rights reserved. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Society for Healthcare Epidemiology of America 2020 2020 The Society for Healthcare Epidemiology of America</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c493t-3405f25de30e9badda7903070e2e924ec984af01b51522902d2d51e679eaad013</citedby><cites>FETCH-LOGICAL-c493t-3405f25de30e9badda7903070e2e924ec984af01b51522902d2d51e679eaad013</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2730823697/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$H</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2730823697?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>230,314,776,780,881,21367,27901,27902,33721,33722,43781,74273</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32772942$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Henderson, David K</creatorcontrib><creatorcontrib>Weber, David J</creatorcontrib><creatorcontrib>Babcock, Hilary</creatorcontrib><creatorcontrib>Hayden, Mary K</creatorcontrib><creatorcontrib>Malani, Anurag</creatorcontrib><creatorcontrib>Wright, Sharon B</creatorcontrib><creatorcontrib>Murthy, A Rekha</creatorcontrib><creatorcontrib>Guzman-Cottrill, Judith</creatorcontrib><creatorcontrib>Haessler, Sarah</creatorcontrib><creatorcontrib>Rock, Clare</creatorcontrib><creatorcontrib>Van Schooneveld, Trevor</creatorcontrib><creatorcontrib>Logan, Latania</creatorcontrib><creatorcontrib>Forde, Corey</creatorcontrib><creatorcontrib>SHEA Board of Trustees</creatorcontrib><creatorcontrib>for the SHEA Board of Trustees</creatorcontrib><title>The perplexing problem of persistently PCR-positive personnel</title><title>Infection control and hospital epidemiology</title><addtitle>Infect Control Hosp Epidemiol</addtitle><description>[...]of using the test-based strategy, many institutions now have significant numbers of staff whose nasopharyngeal swabs remain RT-PCR positive for COVID-19, despite the fact that they have recovered from their episodes of illnesses and have been asymptomatic for weeks or, in some instances, months. [...]regarding the standardization of testing, if the clinical laboratory community developed universal standards for SARS-CoV-2 similar to the World Health Organization’s standards for hepatitis B and C, a multicenter study of all currently manufactured SARS-CoV-2 nucleic acid amplification tests could be designed to correlate the cycle threshold values on each platform for patients who have positive and negative viral cultures. Fewer data are available on viral viability duration in this latter population, and the need for further research on this topic is urgent. [...]based on these data, one approach to managing recovered HCP who work primarily with patient populations at high risk of complications would be to use the “time from symptom development” strategy plus “sustained improvement in respiratory symptoms” and add a safety factor (eg, adding an additional week or 2) to the time from symptom onset, or perhaps adding 2 weeks from test positivity for asymptomatic staff detected as positive. Conflicts of interest All authors report no conflicts of interest relevant to this article. *After this manuscript was submitted and accepted, the Centers for Disease Control and Prevention modified their recommended “return to work” criteria to state that a test-based strategy is no longer recommended and to advocate strategies basically consistent with the suggestions outlined in this paper (See https://www.cdc.gov/coronavirus/2019-ncov/hcp/return-to-work.html).References 1.</description><subject>Asymptomatic</subject><subject>Communicable Diseases</subject><subject>Conflicts of interest</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>Disease control</subject><subject>Disease prevention</subject><subject>Disease transmission</subject><subject>Hospitalization</subject><subject>Humans</subject><subject>Illnesses</subject><subject>Infections</subject><subject>Medical laboratories</subject><subject>Nucleic acids</subject><subject>Pandemics</subject><subject>Patient safety</subject><subject>Polymerase Chain Reaction</subject><subject>SARS-CoV-2</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>State of the Pandemic</subject><issn>0899-823X</issn><issn>1559-6834</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNpdkc1L9DAQh4Mouq7ePMuCFw92nUzSTXPwhZfFLxAUUfAWsu1UI92mJl3R_96sX6ingczDj9_kYWyHw5gDV4eupDECwlhIscIGPM91NimEXGUDKLTOChR3G2wzxkcAUFrzdbYhUCnUEgfs6OaBRh2FrqEX196PuuBnDc1Hvl6-Rhd7avvmdXQ1vc46H13vnt_56NuWmi22Vtsm0vbnHLLbk-Ob6Vl2cXl6Pv1_kZVSiz4TEvIa84oEkJ7ZqrJKgwAFhKRRUqkLaWvgs5zniBqwwirnNFGarK2AiyH795HbLWZzqsrUKdjGdMHNbXg13jrze9O6B3Pvn42SXGklU8D-Z0DwTwuKvZm7WFLT2Jb8IhqUAosJ8lR3yPb-oI9-Edp0nkElIH3nRKtEHXxQZfAxBqq_y3AwSy8meTFLLyZ5SfjuzwO-4S8R4g2T0okV</recordid><startdate>20210201</startdate><enddate>20210201</enddate><creator>Henderson, David K</creator><creator>Weber, David J</creator><creator>Babcock, Hilary</creator><creator>Hayden, Mary K</creator><creator>Malani, Anurag</creator><creator>Wright, Sharon B</creator><creator>Murthy, A Rekha</creator><creator>Guzman-Cottrill, Judith</creator><creator>Haessler, Sarah</creator><creator>Rock, Clare</creator><creator>Van Schooneveld, Trevor</creator><creator>Logan, Latania</creator><creator>Forde, Corey</creator><general>Cambridge University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>S0X</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20210201</creationdate><title>The perplexing problem of persistently PCR-positive personnel</title><author>Henderson, David K ; Weber, David J ; Babcock, Hilary ; Hayden, Mary K ; Malani, Anurag ; Wright, Sharon B ; Murthy, A Rekha ; Guzman-Cottrill, Judith ; Haessler, Sarah ; Rock, Clare ; Van Schooneveld, Trevor ; Logan, Latania ; Forde, Corey</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c493t-3405f25de30e9badda7903070e2e924ec984af01b51522902d2d51e679eaad013</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Asymptomatic</topic><topic>Communicable Diseases</topic><topic>Conflicts of interest</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>Disease control</topic><topic>Disease prevention</topic><topic>Disease transmission</topic><topic>Hospitalization</topic><topic>Humans</topic><topic>Illnesses</topic><topic>Infections</topic><topic>Medical laboratories</topic><topic>Nucleic acids</topic><topic>Pandemics</topic><topic>Patient safety</topic><topic>Polymerase Chain Reaction</topic><topic>SARS-CoV-2</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>State of the Pandemic</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Henderson, David K</creatorcontrib><creatorcontrib>Weber, David J</creatorcontrib><creatorcontrib>Babcock, Hilary</creatorcontrib><creatorcontrib>Hayden, Mary K</creatorcontrib><creatorcontrib>Malani, Anurag</creatorcontrib><creatorcontrib>Wright, Sharon B</creatorcontrib><creatorcontrib>Murthy, A Rekha</creatorcontrib><creatorcontrib>Guzman-Cottrill, Judith</creatorcontrib><creatorcontrib>Haessler, Sarah</creatorcontrib><creatorcontrib>Rock, Clare</creatorcontrib><creatorcontrib>Van Schooneveld, Trevor</creatorcontrib><creatorcontrib>Logan, Latania</creatorcontrib><creatorcontrib>Forde, Corey</creatorcontrib><creatorcontrib>SHEA Board of Trustees</creatorcontrib><creatorcontrib>for the SHEA Board of Trustees</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Infection control and hospital epidemiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Henderson, David K</au><au>Weber, David J</au><au>Babcock, Hilary</au><au>Hayden, Mary K</au><au>Malani, Anurag</au><au>Wright, Sharon B</au><au>Murthy, A Rekha</au><au>Guzman-Cottrill, Judith</au><au>Haessler, Sarah</au><au>Rock, Clare</au><au>Van Schooneveld, Trevor</au><au>Logan, Latania</au><au>Forde, Corey</au><aucorp>SHEA Board of Trustees</aucorp><aucorp>for the SHEA Board of Trustees</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The perplexing problem of persistently PCR-positive personnel</atitle><jtitle>Infection control and hospital epidemiology</jtitle><addtitle>Infect Control Hosp Epidemiol</addtitle><date>2021-02-01</date><risdate>2021</risdate><volume>42</volume><issue>2</issue><spage>203</spage><epage>204</epage><pages>203-204</pages><issn>0899-823X</issn><eissn>1559-6834</eissn><abstract>[...]of using the test-based strategy, many institutions now have significant numbers of staff whose nasopharyngeal swabs remain RT-PCR positive for COVID-19, despite the fact that they have recovered from their episodes of illnesses and have been asymptomatic for weeks or, in some instances, months. [...]regarding the standardization of testing, if the clinical laboratory community developed universal standards for SARS-CoV-2 similar to the World Health Organization’s standards for hepatitis B and C, a multicenter study of all currently manufactured SARS-CoV-2 nucleic acid amplification tests could be designed to correlate the cycle threshold values on each platform for patients who have positive and negative viral cultures. Fewer data are available on viral viability duration in this latter population, and the need for further research on this topic is urgent. [...]based on these data, one approach to managing recovered HCP who work primarily with patient populations at high risk of complications would be to use the “time from symptom development” strategy plus “sustained improvement in respiratory symptoms” and add a safety factor (eg, adding an additional week or 2) to the time from symptom onset, or perhaps adding 2 weeks from test positivity for asymptomatic staff detected as positive. Conflicts of interest All authors report no conflicts of interest relevant to this article. *After this manuscript was submitted and accepted, the Centers for Disease Control and Prevention modified their recommended “return to work” criteria to state that a test-based strategy is no longer recommended and to advocate strategies basically consistent with the suggestions outlined in this paper (See https://www.cdc.gov/coronavirus/2019-ncov/hcp/return-to-work.html).References 1.</abstract><cop>United States</cop><pub>Cambridge University Press</pub><pmid>32772942</pmid><doi>10.1017/ice.2020.343</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0899-823X |
ispartof | Infection control and hospital epidemiology, 2021-02, Vol.42 (2), p.203-204 |
issn | 0899-823X 1559-6834 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7417974 |
source | MEDLINE; ProQuest Central; Cambridge University Press Journals Complete |
subjects | Asymptomatic Communicable Diseases Conflicts of interest Coronaviruses COVID-19 Disease control Disease prevention Disease transmission Hospitalization Humans Illnesses Infections Medical laboratories Nucleic acids Pandemics Patient safety Polymerase Chain Reaction SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 State of the Pandemic |
title | The perplexing problem of persistently PCR-positive personnel |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T16%3A27%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20perplexing%20problem%20of%20persistently%20PCR-positive%20personnel&rft.jtitle=Infection%20control%20and%20hospital%20epidemiology&rft.au=Henderson,%20David%20K&rft.aucorp=SHEA%20Board%20of%20Trustees&rft.date=2021-02-01&rft.volume=42&rft.issue=2&rft.spage=203&rft.epage=204&rft.pages=203-204&rft.issn=0899-823X&rft.eissn=1559-6834&rft_id=info:doi/10.1017/ice.2020.343&rft_dat=%3Cproquest_pubme%3E2730823697%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2730823697&rft_id=info:pmid/32772942&rfr_iscdi=true |